Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Eastman Chemical (EMN)

Eastman Q4 adjusted EPS rises to $1.87 from $1.31; 2025 outlook $8.00-$8.75

Positive Impact 3 of 5 earnings Written later

Eastman Chemical reported fourth-quarter and full-year 2024 results, with sales and per-share earnings both higher than a year earlier. The company also projected 2025 EPS of $8.00-$8.75 and cash from operations of about $1.3 billion.

Key points

  • Q4 2024 sales were $2,245 million, up 2% from $2,207 million; GAAP diluted EPS was $2.82 versus $2.61, and adjusted EPS was $1.87 versus $1.31.
  • Full-year 2024 sales were $9,382 million, up from $9,210 million; GAAP diluted EPS was $7.67 versus $7.49, and adjusted EPS was $7.89 versus $6.40.
  • Q4 2024 GAAP earnings before interest and taxes fell to $349 million from $477 million, which included a 2023 gain on the Texas City sale.
  • For 2025, the company expects EPS of $8.00-$8.75 and cash from operations of about $1.3 billion.

The filing

CompanyEastman Chemical (EMN)
Form8-K, current report
Filed with the SECJan 30, 2025, 4:17 PM ET
Accession number0000915389-25-000007

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 30, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.